De Novo mutations causing shwachman-diamond syndrome and a founder mutation in SBDS in the french canadian population
- Journal of Investigative Genomics
-
Leslie Steele,1 Johanna M Rommens,2,3 Tracy Stockley,1,4 Berivan Baskin,5,6 Peter N Ray1,2,3,5
The Centre for Applied Genomics, The Hospital for Sick Children, Canada - Leslie Steele, Division of Molecular Genetics, The Hospital for Sick Children, Canada
- Johanna M Rommens, Department of Molecular Genetics, University of Toronto, Canada
- Tracy Stockley, Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada
- Peter N Ray, The Centre for Applied Genomics, The Hospital for Sick Children, Canada
Abstract
We summarize the molecular findings in a patient cohort with Shwachman-Diamond syndrome that underwent genetic diagnostic testing. We could confirm a molecular diagnosis in 81 individuals. Our data is consistent with previous findings that the most common mutations in SBDS are recurrent gene conversion mutations in exon 2, c.258+2T>C or c.183_184delinsCT. The patients diagnosed either had two recurrent mutations (78%), or one recurrent mutation and a rare family-specific mutation (22%). We identified six unrelated individuals with SDS of French Canadian decent with the c.120del (p.Arg39fsX) mutation. Molecular analysis revealed that this mutation occurs with a founder haplotype. The opposing SBDS mutation present in these individuals was the common c.258+2T>C mutation, which was on a different haplotype in all five families. In addition, we estimated that approximately 9% (5 out of a subset of 54 patients with parent information) of the SDS individuals had a de novo mutation on one allele and an inherited mutation on the other allele. The de novo mutations were either recurrent gene conversion mutations (n=3) or rare point mutations (n=2). The occurrence of de novo mutation requires that parental carrier testing be performed for accurate familial risk assessment.
Keywords
Shwachman-Diamond syndrome, SBDS, De novo mutation, Genetic testing, Dysfunction, Diagnostic, Sick Children, Cohorts, Canadian Population, Haplotype, Exon, Sanger sequencing, SeqPilot software, Maternity, Proband


